Sofia Parrasia
Padova, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Tumor-specific targeting of a mitochondrial Kv1.3 channel inhibitor through conjugation to gastrin/cholecystokinin B receptor ligand strongly reduces pancreatic ductal adenocarcinoma in orthotopic models.
Journal: Pharmacological research
Published: August 31, 2025
Tumor-specific targeting of a mitochondrial Kv1.3 channel inhibitor through conjugation to gastrin/cholecystokinin B receptor ligand strongly reduces pancreatic ductal adenocarcinoma in orthotopic models.
Journal: Pharmacological research
Published: August 31, 2025
The novel use of the CFTR corrector C17 in muscular dystrophy: pharmacological profile and in vivo efficacy.
Journal: Biochemical pharmacology
Published: October 15, 2024
A novel mertansine conjugate for acid-reversible targeted drug delivery validated through the Avidin-Nucleic-Acid-NanoASsembly platform.
Journal: Nanomedicine : nanotechnology, biology, and medicine
Published: February 18, 2024
Mitochondrial permeability transition pore: a snapshot of a therapeutic target.
Journal: Expert opinion on therapeutic targets
Published: January 18, 2024
Peptides as Pharmacological Carriers to the Brain: Promises, Shortcomings and Challenges.
Journal: Molecular pharmaceutics
Published: September 29, 2022
Multiple Mechanisms Converging on Transcription Factor EB Activation by the Natural Phenol Pterostilbene.
Journal: Oxidative medicine and cellular longevity
Published: July 29, 2021
Targeting Pancreatic Ductal Adenocarcinoma (PDAC).
Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Published: January 15, 2021
An Angiopep2-PAPTP Construct Overcomes the Blood-Brain Barrier. New Perspectives against Brain Tumors.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 18, 2020
Insight into the mechanism of cytotoxicity of membrane-permeant psoralenic Kv1.3 channel inhibitors by chemical dissection of a novel member of the family.
Journal: Redox biology
Published: June 17, 2020
Last Updated: 09/26/2026